Adoptive immunotherapy of murine lymphosarcoma: comparative study using allo-immune or tumor-immune T cells.
No Thumbnail Available
Date
1997-06-01
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The antitumor effect of allosensitization with lymphocytes and skin graft of DBA/2 mice was evaluated using immunogeneic, transplantable Lymphosarcoma (LS-A) syngeneic to Swiss mice. A dose dependent tumor inhibitory effect in terms of tumor free mice was observed in mice sensitized i.p. with lymphocyte doses between 10-100 million per animal. Sensitization with allogeneic primary skin graft was more effective than lymphocyte immunization. The antitumor immunity could be adoptively transferred in syngeneic Swiss mice using either allo-immune or tumor-immune T cells. Analysis of T cell phenotypes using monoclonal antibodies against cell surface markers CD4 and CD8, indicated absolute dependence on the CD4+ T cells subset in tumor cure in case of allo-immune as well as tumor-immune T cells. CD8+ T cell subset was found essential only in case of allo-immune T cell therapy. Immunosuppression of mice with whole body gamma irradiation (4 Gy), 6 hr before transfer of allo-immune or tumor-immune T cells did not abrogate the therapeutic ability of allo-immune or tumor-immune T cells. Our results suggest that allosensitization could be an effective method of generating effector lymphocyte populations that might be used to treat tumors that exhibit detectable immunogenecity.
Description
Keywords
Citation
Thakur VS, Seshadri M, Shah DH, Poduval TB. Adoptive immunotherapy of murine lymphosarcoma: comparative study using allo-immune or tumor-immune T cells. Indian Journal of Experimental Biology. 1997 Jun; 35(6): 581-8